STATE STREET CORP - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$1,471,996
-89.1%
1,705,871
-66.0%
0.00%
-100.0%
Q2 2023$13,538,364
-82.2%
5,014,209
+23.0%
0.00%
-75.0%
Q1 2023$76,061,276
-44.3%
4,076,167
-52.2%
0.00%0.0%
Q4 2022$136,649,864
+148.6%
8,529,954
+101.9%
0.00%
+33.3%
Q3 2022$54,960,000
+12.9%
4,224,450
-8.3%
0.00%0.0%
Q2 2022$48,662,000
-17.8%
4,608,117
-6.5%
0.00%0.0%
Q1 2022$59,232,000
-6.8%
4,927,781
+9.3%
0.00%0.0%
Q4 2021$63,548,000
-4.5%
4,506,953
-30.8%
0.00%
-25.0%
Q3 2021$66,564,000
-26.9%
6,513,075
+90.4%
0.00%
-20.0%
Q2 2021$91,107,000
-13.1%
3,421,216
+13.2%
0.01%
-16.7%
Q1 2021$104,859,000
-11.2%
3,021,009
-5.1%
0.01%
-14.3%
Q4 2020$118,082,000
+2.4%
3,183,655
+13.6%
0.01%
-12.5%
Q3 2020$115,263,000
-8.5%
2,803,092
-9.8%
0.01%
-11.1%
Q2 2020$126,009,000
+36.2%
3,109,040
+16.8%
0.01%
+12.5%
Q1 2020$92,506,000
-18.2%
2,662,038
+0.9%
0.01%0.0%
Q4 2019$113,105,000
+7.2%
2,637,099
-7.6%
0.01%0.0%
Q3 2019$105,496,000
-23.1%
2,852,785
-6.0%
0.01%
-20.0%
Q2 2019$137,177,000
-8.2%
3,036,225
+10.4%
0.01%
-16.7%
Q1 2019$149,484,000
+21.4%
2,750,396
+3.4%
0.01%
+9.1%
Q4 2018$123,158,000
-22.4%
2,661,140
+1.9%
0.01%
-8.3%
Q3 2018$158,716,000
+2.4%
2,612,591
+5.6%
0.01%
-7.7%
Q2 2018$154,936,000
+23.2%
2,475,018
-9.0%
0.01%
+18.2%
Q1 2018$125,719,000
+3.9%
2,721,226
+6.6%
0.01%
+10.0%
Q4 2017$120,977,000
+18.1%
2,552,159
+34.0%
0.01%
+11.1%
Q3 2017$102,478,000
+79.9%
1,904,724
+8.0%
0.01%
+80.0%
Q2 2017$56,962,000
+52.6%
1,763,387
+16.4%
0.01%
+66.7%
Q1 2017$37,336,000
+27.9%
1,514,465
+11.1%
0.00%0.0%
Q4 2016$29,190,000
+8.4%
1,363,658
+4.8%
0.00%0.0%
Q3 2016$26,934,000
+23.5%
1,301,220
-2.1%
0.00%
+50.0%
Q2 2016$21,806,000
-23.0%
1,329,055
-0.1%
0.00%
-33.3%
Q1 2016$28,335,000
-19.6%
1,330,809
+15.1%
0.00%
-25.0%
Q4 2015$35,235,000
+116.7%
1,156,440
+55.9%
0.00%
+100.0%
Q3 2015$16,258,000
+7.9%
741,809
+15.7%
0.00%0.0%
Q2 2015$15,061,000
+360.2%
640,900
+514.9%
0.00%
Q1 2015$3,273,000
+59.1%
104,223
+38.5%
0.00%
Q4 2014$2,057,00075,2460.00%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders